KEVIN HARSH: Open Payments
NPI 1639450356 · LA JUNTA, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$364 in 16 payments from 6 companies in 2025. Trend: 2023 $224 · 2024 $384 · 2025 $364
Food & beverage: $364
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 5 | $120 |
| Teva Pharmaceuticals USA, Inc. | 6 | $117 |
| Alkermes, Inc. | 2 | $65 |
| Vanda Pharmaceuticals Inc. | 1 | $27 |
| HARMONY BIOSCIENCES LLC | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
Products named: INGREZZA, AUSTEDO XR, ARISTADA, PONVORY, WAKIX, CAPLYTA.
Industry payments across CO — which companies pay providers there.
